Mayne Pharma Group Ltd. engages in the development and manufacture of proprietary and generic products. It operates through the following segments: Generic Products, Specialty Products, Metrics Contract Services, and Mayne Pharma International. The Generic Products segment is involved in the manufacture and distribution of generic and branded pharmaceutical products. The Metrics Contract Services segment provides contract pharmaceutical services. The Specialty Products segment includes the distribution of branded pharmaceutical products. The Mayne Pharma International segment manufactures and sells branded and generic pharmaceutical products and provides contract manufacturing services to third party customers within Australia. The company was founded in 1845 and is headquartered in Salisbury, Australia.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
450
Frequently Asked Questions
What is Market Cap of Mayne Pharma Group Limited?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Mayne Pharma Group Limited market cap is $276.64M.
What is the 52-week high for Mayne Pharma Group Limited?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Mayne Pharma Group Limited 52 week high is $4.60 as of September 06, 2025.
What is the 52-week low for Mayne Pharma Group Limited?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Mayne Pharma Group Limited 52 week low is $2.42 as of September 06, 2025.
What is Mayne Pharma Group Limited stock price today?
Mayne Pharma Group Limited stock price today is $3.41.
What was Mayne Pharma Group Limited stock price yesterday?
Mayne Pharma Group Limited stock price yesterday was $3.50.
What is the PE ratio of Mayne Pharma Group Limited?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Mayne Pharma Group Limited’s P/E ratio is -4.59.
What is the Price-to-Book ratio of Mayne Pharma Group Limited?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Mayne Pharma Group Limited P/B ratio is 1.1400.
What is the 50-day moving average of Mayne Pharma Group Limited?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Mayne Pharma Group Limited 50-day moving average is $3.36.
How many employess does Mayne Pharma Group Limited has?